×
About 115,140 results

ALLMedicine™ Cardiovascular Disease Center

Research & Reviews  38,081 results

Interactions between erectile dysfunction, cardiovascular disease and cardiovascular dr...
https://doi.org/10.1038/s41569-021-00593-6 10.1046/j.1464-410X.2002.02911.x 10.1016/j.sxmr.2018.06.005 10.1016/S0022-5347(17)34871-1 10.2174/138161208786898716 10.2164/jandrol.110.011338 10.1016/j.jacc.2019.03.010 10.1093/eurheartj/eht112 10.1093/eurheartj/ehw106 10.1097/HJH.0000000000002382 10.2174/138161209789206980 10.1016/S0140-6736(12)60520-0 10.1038/nrdp.2016.3 10.1016/S0302-2838(03)00307-5 10.1161/CIRCRESAHA.115.305364 10.1016/j.amjcard.2011.03.093 10.1161/HYPERTENSIONAHA.114.03369 10.1111/j.1743-6109.2010.01966.x 10.1016/j.jsxm.2015.11.014 10.1093/eurheartj/ehl341 10.1016/j.jacc.2020.03.081 10.1161/01.CIR.0000148821.97162.5E 10.1161/CIRCULATIONAHA.105.535435 10.1016/j.eururo.2007.08.004 10.1042/CS20200865 10.1093/ajh/hpaa143 10.1016/j.jacc.2015.12.005 10.1093/ajh/hps056 10.1016/j.jsxm.2018.06.012 10.1111/j.1743-6109.2010.02191.x 10.1016/j.jacc.2012.08.1016 10.23736/S0026-4725.20.05136-1 10.1080/14779072.2020.1745632 10.1001/archinte.166.2.207 10.1016/j.atherosclerosis.2009.05.005 10.1016/j.ahj.2007.03.024 10.1016/S0302-2838(03)00305-1 10.1093/eurheartj/ehl142 10.1093/eurheartj/eht308.957 10.1016/j.jsxm.2019.04.004 10.1097/00042307-200411000-00012 10.1016/j.eururo.2005.08.002 10.1053/euhj.1999.1763 10.1093/eurheartj/ehv557 10.1111/ijcp.12275 10.1002/clc.22530 10.1002/ehf2.12108 10.1111/j.2047-2927.2012.00048.x 10.1111/j.1743-6109.2009.01416.x 10.1111/j.1742-1241.2006.01274.x 10.1002/clc.20918 10.1111/j.1743-6109.2011.02350.x 10.1016/j.jsxm.2019.04.012 10.1016/j.eururo.2013.08.023 10.1001/jama.294.23.2996 10.1371/journal.pmed.1001372 10.1016/j.eururo.2011.02.008 10.1097/HJH.0000000000000877 10.1111/j.1743-6109.2010.01744.x 10.1016/j.jacc.2007.10.069 10.1016/j.jacc.2008.02.051 10.1016/j.jacc.2010.04.067 10.2337/dc13-0294 10.1371/journal.pone.0043673 10.1161/CIRCULATIONAHA.109.864199 10.1111/j.1743-6109.2009.01278.x 10.1038/ijir.2009.40 10.1111/j.1743-6109.2012.02826.x 10.1038/sj.ijir.3900472 10.1161/CIRCOUTCOMES.112.966903 10.1161/HYPERTENSIONAHA.117.09633 10.1016/j.jacc.2009.08.058 10.1016/j.jacc.2011.06.024 10.1177/1358863X17725809 10.1111/j.1743-6109.2010.01792.x 10.1007/s00345-018-2318-3 10.1177/2047487318778994 10.1001/jama.2011.336 10.1161/CIR.0b013e3182447787 10.1161/CIRCULATIONAHA.114.012709 10.1016/j.apnr.2015.04.011 10.1016/j.amjmed.2019.06.019 10.1016/j.jsxm.2017.04.673 10.1136/heartjnl-2015-308993 10.1136/heartjnl-2012-302305 10.1177/1474515112473528 10.1016/j.hrtlng.2006.12.001 10.1002/ehf2.12014 10.2174/1570161115666170609101502 10.2164/jandrol.04191 10.1097/HJH.0000000000000519 10.1093/ehjci/ehaa946.2797 10.1111/j.1743-6109.2012.02998.x 10.1097/HJH.0000000000001052 10.1016/j.jsxm.2018.12.007 10.1016/j.jsxm.2019.11.256 10.1007/s10557-021-07197-9 10.1016/j.ehj.2003.08.016 10.1111/j.1745-7262.2006.00076.x 10.1124/jpet.107.135681 10.1038/ijir.2008.28 10.1016/S0090-4295(02)02114-3 10.1056/NEJMoa030656 10.1161/01.HYP.29.1.8 10.1007/s12471-013-0482-z 10.1111/j.1365-2710.1996.tb00006.x 10.1016/j.amjmed.2017.10.043 10.1097/HJH.0b013e3283050886 10.1097/00005392-199805000-00033 10.1038/sj.bjp.0702229 10.1002/phar.2391 10.1111/and.12784 10.1038/sj.ijir.3901516 10.1007/s11154-019-09535-7 10.3390/nu13010108 10.1001/archinternmed.2011.440 10.1016/j.jsxm.2018.02.008 10.1093/eurheartj/eht270 10.1016/j.mayocp.2012.06.015 10.1016/j.sxmr.2018.03.008 10.1016/j.amjcard.2005.03.097 10.1177/1074248418771896 10.1111/j.1743-6109.2011.02537.x 10.1001/jama.2013.2024 10.1111/j.1743-6109.2008.01107.x 10.1016/j.amjhyper.2004.06.027 10.1191/1358863x03vm509ra 10.1016/j.ijcard.2014.12.072 10.1016/j.amjcard.2005.06.091 10.1136/heartjnl-2017-312865 10.1111/bph.14920 10.1136/heartjnl-2016-310746 10.1016/j.jacc.2021.01.045 10.1136/heartjnl-2015-309223 10.1111/ijcp.12779 10.1371/journal.pone.0085805 10.1038/s41569-019-0211-4 10.1016/j.atherosclerosis.2016.04.018 10.1016/j.atherosclerosis.2013.12.010 10.1056/NEJMoa1000485 10.1001/jama.2016.21043 10.1001/jama.2015.8881 10.1159/000351696 10.1080/13685530312331309752 10.1038/sj.ijir.3901174 10.1038/sj.ijir.3901604 10.4065/84.2.108 10.1111/j.1743-6109.2009.01354.x 10.1111/j.1743-6109.2010.01973.x 10.1111/jsm.12918 10.1111/jsm.13032 10.1161/CIRCULATIONAHA.118.033990 10.1016/j.annepidem.2005.06.047 10.1111/j.1743-6109.2005.20230.x 10.1111/j.1440-1681.2007.04551.x 10.1111/j.1755-5922.2009.00123.x 10.1097/00004872-199301000-00015 10.1159/000350955 10.1001/archinte.1991.00400120048008 10.1016/S0149-2918(03)80282-5 10.1097/HJH.0b013e3283455ca5 10.1038/ijir.2009.48 10.1016/j.cjca.2017.09.026 10.1111/j.1464-410X.2012.11241.x
Nature Reviews. Cardiology; Terentes-Printzios D, Ioakeimidis N et. al.

Aug 1st, 2021 - Sexual health has a fundamental role in overall health and well-being, and a healthy and dynamic sex life can make an important contribution to a good quality of life. Sexual dysfunction, and especially erectile dysfunction (ED) in men, is highly ...

Sleep and cardiovascular outcomes in relation to nocturnal hypertension: the J-HOP Noct...
https://doi.org/10.1038/s41440-021-00709-y 10.15585/mmwr.mm6506a1 10.5664/jcsm.26974 10.1161/CIR.0000000000000444 10.1161/JAHA.118.008552 10.1093/eurheartj/ehr007 10.1016/j.sleep.2016.08.006 10.1016/j.smrv.2017.06.011 10.1177/2048872617741733 10.1093/sleep/33.5.585 10.1111/j.1365-2869.2008.00732.x 10.1016/j.amjcard.2018.11.057 10.1016/j.annepidem.2013.03.015 10.1161/01.HYP.0000217362.34748.e0 10.1093/sleep/29.8.1009 10.1161/HYPERTENSIONAHA.120.14790 10.1161/HYPERTENSIONAHA.118.12740 10.1161/01.HYP.0000152079.04553.2c 10.1161/HYPERTENSIONAHA.119.14344 10.1161/HYPERTENSIONAHA.108.124008 10.1016/j.amjhyper.2004.04.001 10.1038/ajh.2009.165 10.1161/CIRCULATIONAHA.120.049730 10.1161/HYPERTENSIONAHA.107.189010 10.1097/HJH.0b013e328308da66 10.1038/hr.2012.56 10.1097/HJH.0000000000001987 10.1093/sleep/33.8.1037 10.1002/sim.1802 10.1038/s41440-018-0130-5 10.1093/sleep/32.3.295 10.1097/MD.0000000000007744 10.1016/j.numecd.2013.12.012 10.1016/j.amjcard.2020.04.012 10.1161/HYPERTENSIONAHA.116.07201 10.1016/j.jsmc.2015.10.007 10.1111/jsr.12160 10.5665/sleep.3028 10.1016/j.jstrokecerebrovasdis.2013.09.009 10.2174/157340310790231635 10.1016/S0735-1097(15)61352-3 10.1152/japplphysiol.01604.2011 10.1152/japplphysiol.00620.2004 10.1007/s11325-013-0873-9 10.1161/01.CIR.0000089191.72957.ED 10.1016/j.jacc.2018.10.060 10.1016/j.atherosclerosis.2006.12.023 10.5888/pcd17.190424
Hypertension Research : Official Journal of the Japanese ... Kario K, Hoshide S et. al.

Aug 1st, 2021 - There is a lack of data on how nighttime blood pressure (BP) might modify the relationship between sleep duration and cardiovascular disease (CVD) risk. Self-reported sleep duration data were available for 2253/2562 patients from the J-HOP Nocturn...

Comparison of Brachial Blood Pressure and Central Blood Pressure in Attended, Unattende...
https://doi.org/10.1038/s41440-021-00694-2 10.1093/eurheartj/ehq024 10.1016/j.jacc.2010.09.054 10.1161/HYPERTENSIONAHA.111.176313 10.1093/eurheartj/eht565 10.1161/HYPERTENSIONAHA.115.06066 10.1111/jch.13110 10.1111/jch.13838 10.1161/HYPERTENSIONAHA.120.14787 10.1161/HYPERTENSIONAHA.107.089078 10.1016/j.jacc.2008.03.031 10.1038/s41440-018-0175-5 10.1056/NEJMoa1511939 10.1161/HYPERTENSIONAHA.117.10479 10.1161/HYPERTENSIONAHA.118.12079 10.1161/HYPERTENSIONAHA.116.07721 10.1016/j.cjca.2018.02.022 10.1093/ajh/hpy131 10.1097/HJH.0000000000002374 10.1016/j.jacc.2015.06.1084 10.1016/j.jash.2016.08.005 10.1038/hr.2011.160 10.3758/BRM.41.4.1149 10.1161/01.HYP.0000168052.00426.65 10.1111/jch.13758 10.1016/j.jacc.2017.11.006 10.1093/eurheartj/ehy339 10.1038/s41440-019-0284-9 10.1161/HYPERTENSIONAHA.113.02741 10.1001/jamacardio.2018.1233 10.1038/s41440-019-0287-6 10.1161/HYPERTENSIONAHA.117.10385 10.1161/HYPERTENSIONAHA.112.193094 10.1016/S0140-6736(10)60308-X 10.1136/bmj.i4098 10.1161/01.HYP.34.4.685 10.1097/01.hjh.0000239289.87141.b6 10.1097/HJH.0000000000000969
Hypertension Research : Official Journal of the Japanese ... Mizuno H, Hoshide S et. al.

Aug 1st, 2021 - Central systolic blood pressure (cSBP) is an independent predictor of future cardiovascular disease. Unattended brachial SBP (bSBP) can eliminate the white-coat effect. However, unattended cSBP and unattended standing cSBP have never been reported...

see more →

Guidelines  118 results

Central and peripheral arterial diseases in chronic kidney disease: conclusions from a ...
https://doi.org/10.1016/j.kint.2021.04.029
Kidney International; Johansen KL, Garimella PS et. al.

May 8th, 2021 - Chronic kidney disease (CKD) affects about 10% of all populations worldwide, with about 2 million people requiring dialysis. Although patients with CKD are at high risk of cardiovascular disease and events, they are often underrepresented or exclu...

2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for ...
https://doi.org/10.1016/j.cjca.2021.03.016
The Canadian Journal of Cardiology; Pearson GJ, Thanassoulis G et. al.

Mar 31st, 2021 - The 2021 guidelines primary panel selected clinically relevant questions and produced updated recommendations, on the basis of important new findings that have emerged since the 2016 guidelines. In patients with clinical atherosclerosis, abdominal...

ACC Health Policy Statement on Cardiovascular Disease Considerations for COVID-19 Vacci...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880623
Journal of the American College of Cardiology; Driggin E, Maddox TM et. al.

Feb 16th, 2021 - ACC Health Policy Statement on Cardiovascular Disease Considerations for COVID-19 Vaccine Prioritization: A Report of the American College of Cardiology Solution Set Oversight Committee.|2021|Driggin E,Maddox TM,Ferdinand KC,Kirkpatrick JN,Ky B,|c...

Taking a Stand Against Air Pollution-The Impact on Cardiovascular Disease: A Joint Opin...
https://doi.org/10.1016/j.jacc.2020.12.003
Journal of the American College of Cardiology; Brauer M, Casadei B et. al.

Feb 2nd, 2021 - Although the attention of the world and the global health community specifically is deservedly focused on the COVID-19 pandemic, other determinants of health continue to have large impacts and may also interact with COVID-19. Air pollution is one ...

AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achie...
https://doi.org/10.1053/j.gastro.2020.11.051
Gastroenterology Younossi ZM, Corey KE et. al.

Dec 12th, 2020 - Nonalcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease, with global public health impact affecting more than 25% of the global population. NAFLD is associated with significant morbidity and mortality from cirrhosis, h...

see more →

Drugs  538 results see all →

Clinicaltrials.gov  1,735 results

Fibre Grain Herb Trial in Type 2 Diabetes
https://clinicaltrials.gov/ct2/show/NCT02553382

May 7th, 2020 - Despite the availability of multiple medications for the treatment of Type 2 diabetes, patients often continue to have difficulty attaining blood glucose targets and managing cardiovascular disease risk factors. Recent trends in non-pharmacologica...

Evaluation of the Pattern of Thyroid Dysfunctions in Patients With Metabolic Syndrome
https://clinicaltrials.gov/ct2/show/NCT03214068

May 5th, 2020 - The metabolic syndrome (MetS) is a clustering of multiple risk factors for atherosclerotic cardiovascular disease such as central obesity, impaired fasting glucose (IFG) or type 2 diabetes mellitus (T2DM), elevated triglyceride (TG), reduced high ...

INcreasing Statin Prescribing in HIV Behavioral Economics REsearch
https://clinicaltrials.gov/ct2/show/NCT03687060

May 5th, 2020 - Cardiovascular disease is a major cause of morbidity and mortality among people living with HIV. Recent studies have demonstrated that patients with HIV experience a 50-100% increased risk of myocardial infarction and stroke compared to HIV-uninfe...

Screening for Asymptomatic Coronary Artery Disease in Kidney Transplant Candidates
https://clinicaltrials.gov/ct2/show/NCT03674307

May 5th, 2020 - Cardiovascular disease is the commonest cause of death while on the kidney transplant waiting list and after transplantation. Current standard care involves screening for coronary artery disease prior to waitlist entry, then every 1-2 years, accor...

Mood Lifters: A Self Help Program
https://clinicaltrials.gov/ct2/show/NCT02558075

May 4th, 2020 - Approximately half the population of the United States will meet criteria for a diagnosable mental illness over their lifetime. Many of these individuals will experience changes in productivity, family relationships and self-esteem. Some will enga...

see more →

News  5,566 results

Analysis Supports CAC for Personalizing Statin Use
https://www.medscape.com/viewarticle/955154

Jul 21st, 2021 - In patients with intermediate risk of atherosclerotic cardiovascular disease along with risk-enhancing factors, coronary artery calcium scoring may help more precisely calculate their need for statin therapy. Furthermore, when the need for statin ...

Cycling Linked to Longer Life in People With Type 2 Diabetes
https://www.medscape.com/viewarticle/955071

Jul 20th, 2021 - Bicycle riding may help people with diabetes live longer, new research suggests. Among more than 7,000 adults with diabetes in 10 Western European countries followed for about 15 years, those who cycled regularly were significantly less likely to ...

New FDA Guidance on T2D Trial Design Provides Flexibility
https://www.medscape.com/viewarticle/954346

Jul 20th, 2021 - This transcript has been edited for clarity. The story of cardiovascular outcomes in diabetes is a fascinating one. There were new developments in the regulatory landscape that really drove the past 10 years of history. If you go way back to the f...

Benefits of Statins Outweigh the Harm from Adverse Events
https://www.medscape.com/viewarticle/955047

Jul 20th, 2021 - Takeaway A meta-analysis found that statin use was associated with an increased risk of self-reported muscle symptoms, liver dysfunction, renal insufficiency and eye conditions. However, the increased risk of adverse events (AEs) did not outweigh ...

Is Aspirin Overused in Older Patients With Diabetes?
https://www.medscape.com/viewarticle/954915

Jul 16th, 2021 - Millions of US adults aged 70 years and over previously advised to take aspirin for primary prevention would not now have it recommended for routine continued use — in particular those with diabetes at low risk of cardiovascular disease (CVD) — sa...

see more →

Patient Education  18 results see all →